Surrozen, Inc./DE (SRZN) stock
SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$29.98−2.34 (-7.24%)
Close on Nov 17, 2026Market cap $352.37MP/E –Yield –
Surrozen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Surrozen's enterprise value was $272.68M on Nov 11, 2026, against $60.77M a year earlier. Over the last 5 years it ranged from -$57.96M to $276.20M, with a median of -$4.32M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $272.68M | +142.7% |
| 2025 | Dec 31, 2025 | $112.37M | +619.1% |
| 2024 | Dec 31, 2024 | $15.63M | – |
| 2023 | Dec 29, 2023 | -$24.24M | – |
| 2022 | Dec 30, 2022 | -$57.96M | -150.2% |
| 2021 | Dec 31, 2021 | $115.40M | – |
See a number that looks wrong?